Enfusion, a provider of cloud-native SaaS solutions for investment managers, released more than 100 enhancements and new features for its Order and Execution Management System (OEMS) in Q1 2022.

Asset managers globally are faced with fee compression, market volatility, and the need to diversify their suite of investment product offerings to meet client demand. Many are launching new investment products, often multi-asset, where the focus is outside of their core strategies. 

As they make this shift, like their hedge fund counterparts, new technologies including SaaS-based Order and Execution Management (OEMS) Systems have gained traction. As reported in Enfusion’s Q1 2022 earnings, Enfusion OEMS bookings accounted for 46% of total bookings in Q1 compared to an average of 25% in the same period last year (+21%).

Enfusion is a complete front-to-back office platform which is built natively as multi-tenant SaaS. It includes a Portfolio Management System, OEMS, General Ledger Accounting System, and Analytics System. Managers can deploy the full platform or individual modules. Enfusion offers its platform across desktop, web, and mobile.